AIDS Commission Needs Gay Panelists

EDITOR'S NOTE: In late May, the White House announced that it would not appoint an openly gay person to the president's new commission on acquired immune deficiency syndrome. Gary L. Bauer, the president's domestic policy adviser, said the administration was opposed to naming a member to the commission—recommended last year by the National Academy of Sciences—solely because he or she was gay. June Osborn, dean of the University of Michigan School of Public Health, organized a group o

Written byDavid Baltimore
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

We are, however, alarmed by recent contradictory efforts which would preclude membership for qualified individuals because of irrelevant criteria. This sort of exclusion is shortsighted and will seriously impede the commission's ability to deal in a balanced fashion with the urgent matters it will inevitably address.

AIDS affects all members of the human family. As we have done so many times before when confronted with a common enemy, we must close ranks, setting aside for the time being past differences of opinion, uniting to defeat the enemy.

In this case the enemy is a disease. While we now know that we are all threatened by it, for the past six years the burden has been principally borne by the gay community here in America. In being forced to deal with the harsh realities of AIDS, they have provided extraordinary leadership in developing innovative prevention, research and treatment strategies. In doing ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies